Company News

Castanea Partners Completes Sale of Decision Resources to Providence Equity Partners

July 9, 2007 - Newton, Massachusetts - Castanea Partners announced today the sale of Decision Resources, Inc. to Providence Equity Partners. Decision Resources is one of the world’s leading research and advisory firms focused on pharmaceutical and healthcare issues. In late 2003, Castanea purchased Decision Resources, in partnership with Boston Ventures Management LLC.

For almost three decades, Decision Resources has provided in-depth research on the trends, emerging developments, and market potential in the healthcare industry. The company leverages its highly educated staff and access to industry thought leaders to offer an array of market leading research publications, data, and advisory services. Decision Resources provides critical insights driving business decisions and commercial success within the biopharmaceutical, managed care, medical device, and financial markets.

“Since Peter Hoenigsberg left Castanea Partners to become CEO of Decision Resources, he and his team have done an outstanding job of accessing new markets and customers by building on the company’s insightful, value-added health care information assets with targeted product development and acquisitions. We wish him and his staff a successful journey ahead” said Robert Smith, co-managing partner of Castanea Partners. 

During its ownership of the company, the Castanea team worked alongside management to expand into additional industry verticals and provided strategic advice in identifying potential targets, resulting in the acquisition of two complementary businesses. At the end of 2004, the company acquired HealthLeaders, and became the country’s leading managed care provider. In early 2006, Decision Resources acquired Millennium Research Group, the leading provider of market research and usage data for the medical device industry.

About Castanea Partners

Founded in 2001, Castanea Partners is a Boston-based private equity firm that invests in small to middle market companies in publishing, education, training, consumer brands, specialty retail, and marketing services. The firm has extensive operating and private equity investment experience in these sectors and, working closely with management, seeks to optimize business performance and realize attractive returns. Castanea participates in traditional management buyouts, sales of private companies, industry consolidation opportunities, growth and acquisition equity, and operationally challenging situations. Castanea is currently investing from its second fund, a $207 million fund that targets companies with enterprise values between $25 and $125 million.


All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

For Potential
Portfolio Companies

  • See what some of our portfolio company business owners have to say about Castanea Partners

    Read more

Press Releases

  • Castanea Partners announces investment in Brew Dr. Kombucha

    FEBRUARY 2018 - Castanea Partners announced today that it has made a minority investment in The Townshend Group, the parent company of Brew Dr. Kombucha.

    Read More

Media Coverage

  • Janet Gurwitch's Interview on MouthMedia Network Beauty Is Your Business Podcast

    MAR 2018 - Download the podcast now on Beauty is Your Business or iTunes.

    Read More

Other News

  • Q&A with Partner at Castanea Partners, Tim Burke

    NOV 2017

    Read more

  • Janet Gurwitch speaks at 2014 Texas ACG Capital Connection

    Play Video

Castanea Partners Three Newton Executive Park, Suite 304, Newton, MA 02462
P (617) 630-2400 | info@castaneapartners.com